Glenn A. Eisenberg - Nov 1, 2022 Form 4 Insider Report for LABORATORY CORP OF AMERICA HOLDINGS (LH)

Role
Chief Financial Officer, EVP
Signature
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Glenn A. Eisenberg
Stock symbol
LH
Transactions as of
Nov 1, 2022
Transactions value $
-$1,190,251
Form type
4
Date filed
11/3/2022, 05:04 PM
Previous filing
Sep 28, 2022
Next filing
Feb 6, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LH Common Stock Options Exercise +12K +44.3% 39.2K Nov 1, 2022 Direct F1
transaction LH Common Stock Tax liability -$1.19M -5.35K -13.65% $222.56 33.8K Nov 1, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LH Performance Share Unit Award $0 +9.17K $0.00 9.17K Nov 1, 2022 Common Stock 9.17K Direct F3, F4, F5
transaction LH Restricted Stock Unit Award $0 +9.17K +54.89% $0.00 25.9K Nov 1, 2022 Common Stock 9.17K Direct F1, F6
transaction LH Restricted Stock Unit Options Exercise $0 -12K -46.5% $0.00 13.8K Nov 1, 2022 Common Stock 12K Direct F1, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F2 Stock withholding to satisfy tax withholding obligations.
F3 Performance Share Unit granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.
F4 Each Performance Share Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
F5 The Performance Share Units vest in full upon the filing of the Company's Quarterly Report on Form 10-Q for the first quarter of 2024, subject to both continued service and a performance condition related to the Issuer's contemplated spin-off transaction.
F6 The Restricted Stock Units vest in full on April 15, 2024.
F7 The Restricted Stock Units that have vested were part of a grant that vested in three installments as follows: 30% of the Restricted Stock Units vested on November 1, 2020; 30% of the Restricted Stock Units vested on November 1, 2021; and 40% of the Restricted Stock Units vested on November 1, 2022, with the third installment subject to a relative total shareholder return ("TSR") modifier that could have adjusted the third installment of the Restricted Stock Units upward or downward 25% based on our three-year cumulative relative TSR but ultimately did not result in an adjustment.
F8 This number reflects the aggregate number of Restricted Stock Units held by the reporting person.